ロード中...
Antibody–Drug Conjugates for Cancer Therapy
Antibody–drug conjugates (ADCs) take advantage of the specificity of a monoclonal antibody to deliver a linked cytotoxic agent directly into a tumour cell. The development of these compounds provides exciting opportunities for improvements in patient care. Here, we review the key issues impacting on...
保存先:
| 出版年: | Biomedicines |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5344263/ https://ncbi.nlm.nih.gov/pubmed/28536381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines4030014 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|